Other

AstraZeneca profits soar on cancer drugs, Alexion buy

Anglo-Swedish drugmaker AstraZeneca on Thursday posted surging annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover.

Medical economics

US leads world in health care spending yet key health outcomes lag

The U.S. spends as much as three times more on health care per person as other high-income countries, yet residents are often less likely to visit doctors, according to a report that highlights poor returns for the nation's ...

page 36 from 40